Cargando…
Malignant epithelioid hemangioendothelioma of the liver successfully treated with Sorafenib
Hepatic epithelioid hemangioendothelioma (HEH) is a rare disease of unknown etiology for which a standard systemic treatment has not been established. The common expression of vascular endothelial growth factor (VEGF) and its receptor in HEH provide a rationale for the reported use of antiangiogenic...
Autores principales: | Sangro, Bruno, Iñarrairaegui, Mercedes, Fernández-Ros, Nerea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401162/ https://www.ncbi.nlm.nih.gov/pubmed/22826791 http://dx.doi.org/10.4081/rt.2012.e34 |
Ejemplares similares
-
Pneumatocele during sorafenib therapy: first report of an unusual complication
por: Sangro, Paloma, et al.
Publicado: (2017) -
Malignant epithelioid hemangioendothelioma of the ear
por: Senaratne, Radha, et al.
Publicado: (2022) -
Pleural Epithelioid Hemangioendothelioma
por: Lee, Young Joo, et al.
Publicado: (2008) -
Oral epithelioid hemangioendothelioma
por: Bhattacharya, Preeti Tomar, et al.
Publicado: (2015) -
Epithelioid hemangioendothelioma of the sternum
por: Song, Wenpeng, et al.
Publicado: (2020)